Cleared Traditional

ULTRASOUND LOCALIZATION SYSTEM ULS 0142 (K040741) - FDA 510(k) Clearance

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2004
Decision
149d
Days
Class 2
Risk

K040741 is an FDA 510(k) clearance for the ULTRASOUND LOCALIZATION SYSTEM ULS 0142. Classified as Lithotriptor, Extracorporeal Shock-wave, Urological (product code LNS), Class II - Special Controls.

Submitted by Hmt High Medical Technologies AG (Washington, US). The FDA issued a Cleared decision on August 19, 2004 after a review of 149 days - within the typical 510(k) review window.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5990 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Hmt High Medical Technologies AG devices

Submission Details

510(k) Number K040741 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 23, 2004
Decision Date August 19, 2004
Days to Decision 149 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
19d slower than avg
Panel avg: 130d · This submission: 149d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNS Lithotriptor, Extracorporeal Shock-wave, Urological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5990
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - LNS Lithotriptor, Extracorporeal Shock-wave, Urological

All 55
Devices cleared under the same product code (LNS) and FDA review panel - the closest regulatory comparables to K040741.
Break Wave
K261086 · Sonomotion, Inc. · Apr 2026
Break Wave
K252913 · Sonomotion, Inc. · Jan 2026
Extracorporeal Shock Wave Lithotripter (U200)
K242922 · Shenzhen Wikkon Precision Technologies Co., Ltd. · Jun 2025
Delta III Pro
K221903 · Dornier Medtech America, Inc. · Feb 2023
LM-9300 Plus Lithotripter
K213772 · Lite-Med, Inc. · Jan 2023
Modulith SLX-F2
K201001 · Karl Storz Endoscopy America · Mar 2021